TD Cowen Maintains Buy on MDxHealth, Lowers Price Target to $1.5
Benzinga Newsdesk 5 months ago
NewsPrice TargetAnalyst Ratings
TD Cowen analyst Dan Brennan maintains MDxHealth (NASDAQ:MDXH) with a Buy and lowers the price target from $7 to $1.5.
TD Cowen analyst Dan Brennan maintains MDxHealth (NASDAQ:MDXH) with a Buy and lowers the price target from $7 to $1.5.